{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T18:09:35Z","timestamp":1776362975150,"version":"3.51.2"},"reference-count":181,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T00:00:00Z","timestamp":1707782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:p>Huntington\u2019s disease is an inherited disorder characterized by psychiatric, cognitive, and motor symptoms due to degeneration of medium spiny neurons in the striatum. A prodromal phase precedes the onset, lasting decades. Current biomarkers include clinical score and striatal atrophy using Magnetic Resonance Imaging (MRI). These markers lack sensitivity for subtle cellular changes during the prodromal phase. MRI and MR spectroscopy offer different contrasts for assessing metabolic, microstructural, functional, or vascular alterations in the disease. They have been used in patients and mouse models. Mouse models can be of great interest to study a specific mechanism of the degenerative process, allow better understanding of the pathogenesis from the prodromal to the symptomatic phase, and to evaluate therapeutic efficacy. Mouse models can be divided into three different constructions: transgenic mice expressing exon-1 of human huntingtin (HTT), mice with an artificial chromosome expressing full-length human HTT, and knock-in mouse models with CAG expansion inserted in the murine htt gene. Several studies have used MRI\/S to characterized these models. However, the multiplicity of modalities and mouse models available complicates the understanding of this rich corpus. The present review aims at giving an overview of results obtained using MRI\/S for each mouse model of HD, to provide a useful resource for the conception of neuroimaging studies using mouse models of HD. Finally, despite difficulties in translating preclinical protocols to clinical applications, many biomarkers identified in preclinical models have already been evaluated in patients. This review also aims to cover this aspect to demonstrate the importance of MRI\/S for studying HD.<\/jats:p>","DOI":"10.3389\/fnagi.2024.1306312","type":"journal-article","created":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T04:22:09Z","timestamp":1707798129000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["The contribution of preclinical magnetic resonance imaging and spectroscopy to Huntington\u2019s disease"],"prefix":"10.3389","volume":"16","author":[{"given":"Jean-Baptiste","family":"P\u00e9rot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Brouillet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Flament","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,13]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"13101","DOI":"10.1038\/s41598-021-92532-1","article-title":"Multiparametric characterization of white matter alterations in early stage Huntington disease","volume":"11","author":"Adanyeguh","year":"2021","journal-title":"Sci. Rep."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"108951","DOI":"10.1016\/j.jneumeth.2020.108951","article-title":"The sensitivity of diffusion MRI to microstructural properties and experimental factors","volume":"347","author":"Afzali","year":"2021","journal-title":"J. Neurosci. Methods"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1016\/j.neuroimage.2012.01.141","article-title":"Spatiotemporal mapping of brain atrophy in mouse models of Huntington\u2019s disease using longitudinal in vivo magnetic resonance imaging","volume":"60","author":"Aggarwal","year":"2012","journal-title":"NeuroImage"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s10278-017-9983-4","article-title":"Deep learning for brain MRI segmentation: state of the art and future directions","volume":"30","author":"Akkus","year":"2017","journal-title":"J. Digit. Imaging"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1093\/cercor\/bhs352","article-title":"Tracking whole-brain connectivity dynamics in the resting state","volume":"24","author":"Allen","year":"2014","journal-title":"Cereb. Cortex"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/mds.28839","article-title":"Structure and dynamics of large-scale cognitive networks in Huntington\u2019s disease","volume":"37","author":"Aracil-Bola\u00f1os","year":"2022","journal-title":"Mov. Disord."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/nature02998","article-title":"Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death","volume":"431","author":"Arrasate","year":"2004","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.neuroimage.2010.02.056","article-title":"Feasibility of mapping the tissue mass corrected bioscale of cerebral metabolic rate of oxygen consumption using 17-oxygen and 23-sodium MR imaging in a human brain at 9.4T","volume":"51","author":"Atkinson","year":"2010","journal-title":"NeuroImage"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1148\/radiol.14132388","article-title":"Resting-state functional MR imaging: a new window to the brain","volume":"272","author":"Barkhof","year":"2014","journal-title":"Radiology"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nrn1386","article-title":"Experimental therapeutics in transgenic mouse models of Huntington\u2019s disease","volume":"5","author":"Beal","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e0206613","DOI":"10.1371\/journal.pone.0206613","article-title":"MR-based spatial normalization improves [18F]MNI-659 PET regional quantification and detectability of disease effect in the Q175 mouse model of Huntington\u2019s disease","volume":"13","author":"Bertoglio","year":"2018","journal-title":"PLoS One"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.bbrc.2004.08.035","article-title":"Deranged neuronal calcium signaling and Huntington disease","volume":"322","author":"Bezprozvanny","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.neuroscience.2017.05.042","article-title":"Myelin breakdown in human Huntington\u2019s disease: multi-modal evidence from diffusion MRI and quantitative magnetization transfer","volume":"403","author":"Bourbon-Teles","year":"2019","journal-title":"Neuroscience"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.brainresbull.2010.05.005","article-title":"Longitudinal analysis of the behavioural phenotype in YAC128 (C57BL\/6J) Huntington\u2019s disease transgenic mice","volume":"88","author":"Brooks","year":"2012","journal-title":"Brain Res. Bull."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.brainresbull.2010.05.004","article-title":"Longitudinal analysis of the behavioural phenotype in Hdh(CAG)150 Huntington\u2019s disease knock-in mice","volume":"88","author":"Brooks","year":"2012","journal-title":"Brain Res. Bull."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.brainresbull.2011.06.008","article-title":"Longitudinal analyses of operant performance on the serial implicit learning task (SILT) in the YAC128 Huntington\u2019s disease mouse line","volume":"88","author":"Brooks","year":"2012","journal-title":"Brain Res. Bull."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0301-0082(99)00005-2","article-title":"Replicating Huntington\u2019s disease phenotype in experimental animals","volume":"59","author":"Brouillet","year":"1999","journal-title":"Prog. Neurobiol."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.conb.2021.07.001","article-title":"Polyglutamine diseases","volume":"72","author":"Bunting","year":"2022","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.nbd.2011.03.018","article-title":"Natural history of disease in the YAC128 mouse reveals a discrete signature of pathology in Huntington disease","volume":"43","author":"Carroll","year":"","journal-title":"Neurobiol. Dis."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1750-1326-6-59","article-title":"Mice lacking caspase-2 are protected from behavioral changes, but not pathology, in the YAC128 model of Huntington disease","volume":"6","author":"Carroll","year":"","journal-title":"Mol. Neurodegener."},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1002\/hbm.25859","article-title":"Mutation-related magnetization-transfer, not axon density, drives white matter differences in premanifest Huntington disease: evidence from in vivo ultrastrong gradient MRI","volume":"43","author":"Casella","year":"2022","journal-title":"Human Brain Mapping"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"9280","DOI":"10.1073\/pnas.1016190108","article-title":"Changes in striatal procedural memory coding correlate with learning deficits in a mouse model of Huntington disease","volume":"108","author":"Cayzac","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"6456","DOI":"10.1523\/JNEUROSCI.0388-12.2012","article-title":"R6\/2 Huntington\u2019s disease mice develop early and progressive abnormal brain metabolism and seizures","volume":"32","author":"Cepeda-Prado","year":"2012","journal-title":"J. Neurosci."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e4007","DOI":"10.1002\/nbm.4007","article-title":"Connectomic imaging reveals Huntington-related pathological and pharmaceutical effects in a mouse model","volume":"31","author":"Chang","year":"2018","journal-title":"NMR Biomed."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.neuroimage.2011.08.112","article-title":"Complex relationships between cerebral blood flow and brain atrophy in early Huntington\u2019s disease","volume":"59","author":"Chen","year":"2012","journal-title":"NeuroImage"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.neuroimage.2011.02.022","article-title":"Structural MRI detects progressive regional brain atrophy and neuroprotective effects in N171-82Q Huntington\u2019s disease mouse model","volume":"56","author":"Cheng","year":"2011","journal-title":"NeuroImage"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.nic.2011.02.007","article-title":"MR perfusion imaging in acute ischemic stroke","volume":"21","author":"Copen","year":"2011","journal-title":"Neuroimaging Clin. N. Am."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3390\/molecules25030482","article-title":"Huntington\u2019s disease: a review of the known PET imaging biomarkers and targeting radiotracers","volume":"25","author":"Cybulska","year":"2020","journal-title":"Molecules"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.3174\/ajnr.A2128","article-title":"Regional distribution and clinical correlates of White matter structural damage in Huntington disease: a tract-based spatial statistics study","volume":"31","author":"Della Nave","year":"2010","journal-title":"Am. J. Neuroradiol."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1007\/s00415-011-6099-5","article-title":"Exploratory 7-tesla magnetic resonance spectroscopy in Huntington\u2019s disease provides in vivo evidence for impaired energy metabolism","volume":"258","author":"den Bogaard","year":"2011","journal-title":"J. Neurol."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1002\/hbm.22391","article-title":"MRI measures of corpus callosum iron and myelin in early Huntington\u2019s disease","volume":"35","author":"di Paola","year":"2014","journal-title":"Hum. Brain Mapp."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/ajmg.a.38494","article-title":"Therapy development in Huntington disease: from current strategies to emerging opportunities","volume":"176","author":"Dickey","year":"2018","journal-title":"Am. J. Med. Genet. A"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.neuroimage.2009.03.044","article-title":"In vivo evidence for the selective subcortical degeneration in Huntington\u2019s disease","volume":"46","author":"Douaud","year":"2009","journal-title":"NeuroImage"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/ana.24406","article-title":"Cerebrovascular and blood\u2013brain barrier impairments in Huntington\u2019s disease: potential implications for its pathophysiology","volume":"78","author":"Drouin-Ouellet","year":"2015","journal-title":"Ann. Neurol."},{"key":"ref36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-1-4939-7825-0_6","article-title":"Mouse models of Huntington\u2019s disease","volume-title":"Huntington\u2019s disease","author":"Farshim","year":"2018"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.bbadis.2009.04.001","article-title":"Mouse models of Huntington\u2019s disease and methodological considerations for therapeutic trials","volume":"1792","author":"Ferrante","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1523\/JNEUROSCI.22-05-01592.2002","article-title":"Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington\u2019s disease","volume":"22","author":"Ferrante","year":"2002","journal-title":"J. Neurosci."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/mds.28855","article-title":"An MDS evidence-based review on treatments for Huntington\u2019s disease","volume":"37","author":"Ferreira","year":"2022","journal-title":"Mov. Disord."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3389\/fneur.2014.00094","article-title":"Studies on the Q175 Knock-in model of Huntington\u2019s disease using functional imaging in awake mice: evidence of olfactory dysfunction","volume":"5","author":"Ferris","year":"2014","journal-title":"Front. Neurol."},{"key":"ref41","first-page":"320","article-title":"Functional magnetic resonance imaging: the basics of blood-oxygen-level dependent (BOLD) imaging","volume":"49","author":"Forster","year":"1998","journal-title":"Can. Assoc. Radiol. J."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s00401-021-02362-8","article-title":"Early white matter pathology in the fornix of the limbic system in Huntington disease","volume":"142","author":"Gabery","year":"2021","journal-title":"Acta Neuropathol."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00401-010-0742-6","article-title":"Changes in key hypothalamic neuropeptide populations in Huntington disease revealed by neuropathological analyses","volume":"120","author":"Gabery","year":"2010","journal-title":"Acta Neuropathol."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"31652","DOI":"10.1038\/srep31652","article-title":"Laquinimod rescues striatal, cortical and white matter pathology and results in modest behavioural improvements in the YAC128 model of Huntington disease","volume":"6","author":"Garcia-Miralles","year":"2016","journal-title":"Sci. Rep."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"4112","DOI":"10.1002\/hbm.23299","article-title":"Longitudinal changes in functional connectivity of cortico-basal ganglia networks in manifests and premanifest huntington\u2019s disease","volume":"37","author":"Gargouri","year":"2016","journal-title":"Hum. Brain Mapp."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"5285","DOI":"10.1093\/hmg\/ddv248","article-title":"Analysis of YFP(J16)-R6\/2 reporter mice and postmortem brains reveals early pathology and increased vulnerability of callosal axons in Huntington\u2019s disease","volume":"24","author":"Gatto","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"983","DOI":"10.4103\/1673-5374.324831","article-title":"Preliminary examination of early neuroconnectivity features in the R6\/1 mouse model of Huntington\u2019s disease by ultra-high field diffusion MRI","volume":"17","author":"Gatto","year":"2022","journal-title":"Neural Regen. Res."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.neurobiolaging.2021.02.006","article-title":"Evaluation of early microstructural changes in the R6\/1 mouse model of Huntington\u2019s disease by ultra-high field diffusion MR imaging","volume":"102","author":"Gatto","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s10334-019-00742-6","article-title":"Detection of axonal degeneration in a mouse model of Huntington\u2019s disease: comparison between diffusion tensor imaging and anomalous diffusion metrics","volume":"32","author":"Gatto","year":"2019","journal-title":"Magn. Reson. Mater. Phys."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","article-title":"Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules","volume":"118","author":"Gauthier","year":"2004","journal-title":"Cell"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.3174\/ajnr.A2225","article-title":"Magnetization transfer MR imaging demonstrates degeneration of the subcortical and cortical gray matter in Huntington disease","volume":"31","author":"Ginestroni","year":"2010","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/mds.28089","article-title":"Dysregulated brain cholesterol metabolism is linked to Neuroinflammation in Huntington\u2019s disease","volume":"35","author":"Gonz\u00e1lez-Guevara","year":"2020","journal-title":"Mov. Disord."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0896-6273(03)00594-4","article-title":"Disruption of axonal transport by loss of huntingtin or expression of pathogenic PolyQ proteins in Drosophila","volume":"40","author":"Gunawardena","year":"2003","journal-title":"Neuron"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/ana.410310113","article-title":"Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington\u2019s disease","volume":"31","author":"Harris","year":"1992","journal-title":"Ann. Neurol."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"e50717","DOI":"10.1371\/journal.pone.0050717","article-title":"Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington\u2019s disease","volume":"7","author":"Heikkinen","year":"2012","journal-title":"PLoS One"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10334-015-0518-z","article-title":"Segmentation of human brain using structural MRI","volume":"29","author":"Helms","year":"2016","journal-title":"Magn. Reson. Mater. Phys."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.neuroscience.2008.08.041","article-title":"Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in Knock-in Huntington\u2019s disease mice","volume":"157","author":"Hickey","year":"2008","journal-title":"Neuroscience"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/nbm.3855","article-title":"Transit time mapping in the mouse brain using time-encoded pCASL","volume":"31","author":"Hirschler","year":"2018","journal-title":"NMR Biomed."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/ana.24428","article-title":"Aberrant astrocytes impair vascular reactivity in Huntington disease","volume":"78","author":"Hsiao","year":"2015","journal-title":"Ann. Neurol."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/mrm.22775","article-title":"Inflow-based vascular-space-occupancy (iVASO) MRI","volume":"66","author":"Hua","year":"2011","journal-title":"Magn. Reson. Med."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/mds.25591","article-title":"Elevated arteriolar cerebral blood volume in prodromal Huntington\u2019s disease","volume":"29","author":"Hua","year":"2014","journal-title":"Mov. Disord."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/j.1471-4159.2005.03411.x","article-title":"Effects of CAG repeat length, HTT protein length and protein context on cerebral metabolism measured using magnetic resonance spectroscopy in transgenic mouse models of Huntington\u2019s disease","volume":"95","author":"Jenkins","year":"2005","journal-title":"J. Neurochem."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1046\/j.1471-4159.2000.0742108.x","article-title":"Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington\u2019s disease mice","volume":"74","author":"Jenkins","year":"2000","journal-title":"J. Neurochem."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/0006-3223(91)90211-4","article-title":"Cerebral structure on MRI, part II: specific changes in Alzheimer\u2019s and Huntington\u2019s diseases","volume":"29","author":"Jernigan","year":"1991","journal-title":"Biol. Psychiatry"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1177\/0271678X17743240","article-title":"Arterial spin labeling for the measurement of cerebral perfusion and angiography","volume":"38","author":"Jezzard","year":"2018","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref66","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nm.2558","article-title":"Neuroprotective role of Sirt1 in mammalian models of Huntington\u2019s disease through activation of multiple Sirt1 targets","volume":"18","author":"Jiang","year":"2011","journal-title":"Nat. Med."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1093\/hmg\/ddv016","article-title":"Early white matter abnormalities, progressive brain pathology and motor deficits in a novel knock-in mouse model of Huntington\u2019s disease","volume":"24","author":"Jin","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref68","doi-asserted-by":"publisher","first-page":"103266","DOI":"10.1016\/j.ebiom.2021.103266","article-title":"Altered iron and myelin in premanifest Huntington\u2019s disease more than 20 years before clinical onset: evidence from the cross-sectional HD Young adult study","volume":"65","author":"Johnson","year":"2021","journal-title":"EBioMedicine"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1093\/brain\/awz174","article-title":"CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington\u2019s disease","volume":"142","author":"Kacher","year":"2019","journal-title":"Brain"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"797220","DOI":"10.3389\/fnagi.2022.797220","article-title":"Altered cholesterol homeostasis in Huntington\u2019s disease","volume":"14","author":"Kacher","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/1531-8249(199912)46:6<842::AID-ANA6>3.0.CO;2-O","article-title":"Huntington aggregates may not predict neuronal death in Huntington\u2019s disease","volume":"46","author":"Kuemmerle","year":"1999","journal-title":"Ann. Neurol."},{"key":"ref72","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3174\/ajnr.A6484","article-title":"Advanced multicompartment diffusion MRI models and their application in multiple sclerosis","volume":"41","author":"Lakhani","year":"2020","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3233\/JHD-140094","article-title":"Rhes suppression enhances disease phenotypes in Huntington\u2019s disease mice","volume":"3","author":"Lee","year":"2014","journal-title":"J. Huntington Dis."},{"key":"ref74","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.neuroimage.2008.02.019","article-title":"Cortical thickness measured from MRI in the YAC128 mouse model of Huntington\u2019s disease","volume":"41","author":"Lerch","year":"","journal-title":"NeuroImage"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.neuroimage.2007.08.033","article-title":"Automated deformation analysis in the YAC128 Huntington disease mouse model","volume":"39","author":"Lerch","year":"","journal-title":"NeuroImage"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.nbd.2012.11.014","article-title":"Regional vulnerability in Huntington\u2019s disease: fMRI-guided molecular analysis in patients and a mouse model of disease","volume":"52","author":"Lewandowski","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"ref77","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1093\/hmg\/ddg218","article-title":"Abnormal association of mutant huntingtin with synaptic vesicles inhibits glutamate release","volume":"12","author":"Li","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"ref78","first-page":"1","article-title":"Resting-state functional MRI reveals altered brain connectivity and its correlation with motor dysfunction in a mouse model of Huntington\u2019s disease","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"key":"ref79","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.expneurol.2013.08.019","article-title":"Neurovascular abnormalities in humans and mice with Huntington\u2019s disease","volume":"250","author":"Lin","year":"2013","journal-title":"Exp. Neurol."},{"key":"ref80","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.neuroimage.2008.12.030","article-title":"In vivo cerebromicrovasculatural visualization using 3D \u0394R2-based microscopy of magnetic resonance angiography (3D\u0394R2-mMRA)","volume":"45","author":"Lin","year":"2009","journal-title":"NeuroImage"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/hmg\/10.2.137","article-title":"Neurological abnormalities in a knock-in mouse model of Huntington\u2019s disease","volume":"10","author":"Lin","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"ref82","doi-asserted-by":"publisher","first-page":"10428","DOI":"10.1523\/JNEUROSCI.19-23-10428.1999","article-title":"Selective discrimination learning impairments in mice expressing the human Huntington\u2019s disease mutation","volume":"19","author":"Lione","year":"1999","journal-title":"J. Neurosci."},{"key":"ref83","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.bbrc.2016.09.065","article-title":"Energy defects in Huntington\u2019s disease: why \u2018in vivo\u2019 evidence matters","volume":"483","author":"Liot","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref84","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1093\/brain\/awab190","article-title":"Huntingtin silencing delays onset and slows progression of Huntington\u2019s disease: a biomarker study","volume":"144","author":"Liu","year":"2021","journal-title":"Brain"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1093\/hmg\/ddl125","article-title":"Genetic background modifies nuclear mutant huntingtin accumulation and HD CAG repeat instability in Huntington\u2019s disease knock-in mice","volume":"15","author":"Lloret","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"ref86","first-page":"2813","article-title":"Oxygen consumption deficit in Huntington disease mouse brain under metabolic stress","volume":"25","author":"Lou","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref87","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"8772","DOI":"10.1523\/JNEUROSCI.21-22-08772.2001","article-title":"Proteasomal-dependent aggregate reversal and absence of cell death in a conditional mouse model of Huntington\u2019s disease","volume":"21","author":"Mart\u00edn-Aparicio","year":"2001","journal-title":"J. Neurosci."},{"key":"ref89","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1523\/JNEUROSCI.4320-04.2005","article-title":"Deficits in experience-dependent cortical plasticity and sensory-discrimination learning in presymptomatic Huntington\u2019s disease mice","volume":"25","author":"Mazarakis","year":"2005","journal-title":"J. Neurosci."},{"key":"ref90","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.13413","article-title":"Huntington\u2019s disease: a clinical review","volume":"25","author":"McColgan","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"ref91","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1602\/neurorx.2.3.465","article-title":"Knock-in mouse models of Huntington\u2019s disease","volume":"2","author":"Menalled","year":"2005","journal-title":"NeuroRx"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0165-6147(00)01884-8","article-title":"Mouse models of Huntington\u2019s disease","volume":"23","author":"Menalled","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"ref93","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.nbd.2009.05.007","article-title":"Systematic behavioral evaluation of Huntington\u2019s disease transgenic and knock-in mouse models","volume":"35","author":"Menalled","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"ref94","doi-asserted-by":"publisher","first-page":"e49838","DOI":"10.1371\/journal.pone.0049838","article-title":"Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington\u2019s disease: zQ175","volume":"7","author":"Menalled","year":"2012","journal-title":"PLoS One"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/cne.10776","article-title":"Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington\u2019s disease with 140 CAG repeats","volume":"465","author":"Menalled","year":"2003","journal-title":"J. Comp. Neurol."},{"key":"ref96","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/mds.25009","article-title":"Abnormal response to cortical activation in early stages of Huntington disease","volume":"27","author":"Mochel","year":"2012","journal-title":"Mov. Disord."},{"key":"ref97","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1001\/archneur.64.10.1467","article-title":"Imaging the A\u03b2-related neurotoxicity of Alzheimer disease","volume":"64","author":"Moreno","year":"2007","journal-title":"Arch. Neurol."},{"key":"ref98","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1097\/00005072-199111000-00005","article-title":"Decreased neuronal and increased oligodendroglial densities in Huntington\u2019s disease caudate nucleus","volume":"50","author":"Myers","year":"1991","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref99","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.neuroscience.2003.08.053","article-title":"Molecular and behavioral analysis of the R6\/1 Huntington\u2019s disease transgenic mouse","volume":"122","author":"Naver","year":"2003","journal-title":"Neuroscience"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"711651","DOI":"10.3389\/fnins.2021.711651","article-title":"Fixel-based analysis effectively identifies White matter tract degeneration in Huntington\u2019s disease","volume":"15","author":"Oh","year":"2021","journal-title":"Front. Neurosci."},{"key":"ref101","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1523\/JNEUROSCI.0106-08.2008","article-title":"N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking","volume":"28","author":"Orr","year":"2008","journal-title":"J. Neurosci."},{"key":"ref102","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2217\/fnl.12.51","article-title":"Evidence from the R6\/2 mouse model of Huntington\u2019s disease for using abnormal brain metabolism as a biomarker for evaluating therapeutic approaches for treatment","volume":"7","author":"Parievsky","year":"2012","journal-title":"Future Neurol."},{"key":"ref103","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.expneurol.2008.12.015","article-title":"Functional imaging in Huntington\u2019s disease","volume":"216","author":"Paulsen","year":"2009","journal-title":"Exp. Neurol."},{"key":"ref104","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.brainresbull.2010.04.003","article-title":"Striatal and white matter predictors of estimated diagnosis for Huntington disease","volume":"82","author":"Paulsen","year":"2010","journal-title":"Brain Res. Bull."},{"key":"ref105","doi-asserted-by":"publisher","first-page":"e0148839","DOI":"10.1371\/journal.pone.0148839","article-title":"Characterization of behavioral, neuropathological, brain metabolic and key molecular changes in zQ175 Knock-in mouse model of Huntington\u2019s disease","volume":"11","author":"Peng","year":"2016","journal-title":"PLoS One"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/nbm.4301","article-title":"Complementarity of gluCEST and 1 H-MRS for the study of mouse models of Huntington\u2019s disease","volume":"33","author":"P\u00e9pin","year":"2020","journal-title":"NMR Biomed."},{"key":"ref107","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.neuroimage.2016.06.023","article-title":"In vivo imaging of brain glutamate defects in a knock-in mouse model of Huntington\u2019s disease","volume":"139","author":"P\u00e9pin","year":"2016","journal-title":"NeuroImage"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.1093\/hmg\/ddac036","article-title":"Longitudinal multimodal MRI characterization of a knock-in mouse model of Huntington\u2019s disease reveals early grey and white matter alterations","volume":"31","author":"P\u00e9rot","year":"2022","journal-title":"Hum. Mol. Genet."},{"key":"ref109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/exnr.1998.7006","article-title":"Recent advances on the pathogenesis of Huntington\u2019s disease","volume":"157","author":"Peters\u00e9n","year":"1999","journal-title":"Exp. Neurol."},{"key":"ref110","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1093\/hmg\/ddy119","article-title":"A whole brain longitudinal study in the YAC128 mouse model of Huntington\u2019s disease shows distinct trajectories of neurochemical, structural connectivity and volumetric changes","volume":"27","author":"Petrella","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"ref111","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0140-6736(83)90088-0","article-title":"CEREBRAL pH BY NMR","volume":"322","author":"Petroff","year":"1983","journal-title":"Lancet"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3389\/fnins.2016.00197","article-title":"Major superficial White matter abnormalities in Huntington\u2019s disease","volume":"10","author":"Phillips","year":"2016","journal-title":"Front. Neurosci."},{"key":"ref113","doi-asserted-by":"publisher","first-page":"e73280","DOI":"10.1371\/journal.pone.0073280","article-title":"Tractography of the corpus callosum in Huntington\u2019s disease","volume":"8","author":"Phillips","year":"2013","journal-title":"PLoS One"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.nbd.2014.12.009","article-title":"Longitudinal change in white matter microstructure in Huntington\u2019s disease: the IMAGE-HD study","volume":"74","author":"Poudel","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"ref115","first-page":"1243","article-title":"Huntingtin processing in pathogenesis of Huntington disease","volume":"25","author":"Qin","year":"2004","journal-title":"Acta Pharmacol. Sin."},{"key":"ref116","doi-asserted-by":"publisher","first-page":"e72159","DOI":"10.1371\/journal.pone.0072159","article-title":"Default-mode network changes in Huntington\u2019s disease: an integrated MRI study of functional connectivity and morphometry","volume":"8","author":"Quarantelli","year":"2013","journal-title":"PLoS One"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1093\/ilar.48.4.356","article-title":"Animal models of Huntington\u2019s disease","volume":"48","author":"Ramaswamy","year":"2007","journal-title":"ILAR J."},{"key":"ref118","doi-asserted-by":"publisher","first-page":"e84726","DOI":"10.1371\/journal.pone.0084726","article-title":"Correlations of behavioral deficits with brain pathology assessed through longitudinal MRI and histopathology in the R6\/1 mouse model of Huntington\u2019s disease","volume":"8","author":"Rattray","year":"2013","journal-title":"PLoS One"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"e0168556","DOI":"10.1371\/journal.pone.0168556","article-title":"Correlations of behavioral deficits with brain pathology assessed through longitudinal MRI and histopathology in the HdhQ150\/Q150 mouse model of Huntington\u2019s disease","volume":"12","author":"Rattray","year":"2017","journal-title":"PLoS One"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"e60012","DOI":"10.1371\/journal.pone.0060012","article-title":"Correlations of behavioral deficits with brain pathology assessed through longitudinal MRI and histopathology in the R6\/2 mouse model of HD","volume":"8","author":"Rattray","year":"2013","journal-title":"PLoS One"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/cns.12828","article-title":"Corticostriatal network dysfunction in Huntington\u2019s disease: deficits in neural processing, glutamate transport, and ascorbate release","volume":"24","author":"Rebec","year":"2018","journal-title":"CNS Neurosci. Ther."},{"key":"ref122","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.brainres.2004.10.030","article-title":"Heterogeneity in 1H-MRS profiles of presymptomatic and early manifest Huntington\u2019s disease","volume":"1031","author":"Reynolds","year":"2005","journal-title":"Brain Res."},{"key":"ref123","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1002\/mds.22245","article-title":"MR-spectroscopic findings in juvenile-onset Huntington\u2019s disease","volume":"23","author":"Reynolds","year":"2008","journal-title":"Mov. Disord."},{"key":"ref124","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1016\/j.neuroimage.2009.10.015","article-title":"Altered White matter microstructure in the Corpus callosum in Huntington\u2019s disease: implications for cortical \u201cdisconnection\u201d","volume":"49","author":"Rosas","year":"2010","journal-title":"NeuroImage"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0092-8674(00)81782-1","article-title":"Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions","volume":"95","author":"Saudou","year":"1998","journal-title":"Cell"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"6350","DOI":"10.1007\/s12035-021-02556-x","article-title":"Mitochondrial abnormalities and synaptic damage in Huntington\u2019s disease: a focus on defective Mitophagy and mitochondria-targeted therapeutics","volume":"58","author":"Sawant","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"ref127","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.nbd.2008.09.017","article-title":"Use of magnetic resonance imaging for anatomical phenotyping of the R6\/2 mouse model of Huntington\u2019s disease","volume":"33","author":"Sawiak","year":"","journal-title":"Neurobiol. Dis."},{"key":"ref128","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.nbd.2008.09.016","article-title":"Voxel-based morphometry in the R6\/2 transgenic mouse reveals differences between genotypes not seen with manual 2D morphometry","volume":"33","author":"Sawiak","year":"","journal-title":"Neurobiol. Dis."},{"key":"ref129","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","article-title":"Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin","volume":"8","author":"Schilling","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"ref130","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.neuron.2012.05.024","article-title":"Network organization of the huntingtin proteomic interactome in mammalian brain","volume":"75","author":"Shirasaki","year":"2012","journal-title":"Neuron"},{"key":"ref131","doi-asserted-by":"publisher","first-page":"4906","DOI":"10.1073\/pnas.0811228106","article-title":"Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington\u2019s disease knockin mice","volume":"106","author":"Simmons","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"ref133","doi-asserted-by":"publisher","first-page":"3654","DOI":"10.1093\/hmg\/ddw212","article-title":"An enhanced Q175 knock-in mouse model of Huntington disease with higher mutant huntingtin levels and accelerated disease phenotypes","volume":"25","author":"Southwell","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref134","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/cne.20680","article-title":"Chronology of behavioral symptoms and neuropathological sequela in R6\/2 Huntington\u2019s disease transgenic mice","volume":"490","author":"Stack","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"ref135","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1212\/WNL.0b013e3181fc27e4","article-title":"Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease","volume":"75","author":"Sturrock","year":"2010","journal-title":"Neurology"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/mds.26118","article-title":"A longitudinal study of magnetic resonance spectroscopy Huntington\u2019s disease biomarkers","volume":"30","author":"Sturrock","year":"2015","journal-title":"Mov. Disord."},{"key":"ref137","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0168-9525(03)00074-X","article-title":"Transcriptional abnormalities in Huntington disease","volume":"19","author":"Sugars","year":"2003","journal-title":"Trends Genet."},{"key":"ref138","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0896-6273(03)00569-5","article-title":"Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport","volume":"40","author":"Szebenyi","year":"2003","journal-title":"Neuron"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S1474-4422(22)00121-1","article-title":"Potential disease-modifying therapies for Huntington\u2019s disease: lessons learned and future opportunities","volume":"21","author":"Tabrizi","year":"2022","journal-title":"Lancet Neurol."},{"key":"ref140","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","article-title":"Biological and clinical manifestations of Huntington\u2019s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data","volume":"8","author":"Tabrizi","year":"2009","journal-title":"Lancet Neurol."},{"key":"ref141","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jns.2015.03.025","article-title":"Magnetization transfer MRI in dementia disorders, Huntington\u2019s disease and parkinsonism","volume":"353","author":"Tambasco","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"ref142","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0896-6273(03)00366-0","article-title":"Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1","volume":"39","author":"Tang","year":"2003","journal-title":"Neuron"},{"key":"ref143","first-page":"2621","article-title":"Structural and molecular myelination deficits occur prior to neuronal loss in the YAC128 and BACHD models of Huntington disease","volume":"25","author":"Teo","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref144","doi-asserted-by":"publisher","first-page":"e1939","DOI":"10.1212\/WNL.0000000000007355","article-title":"Brain structure in juvenile-onset Huntington disease","volume":"92","author":"Tereshchenko","year":"2019","journal-title":"Neurology"},{"key":"ref145","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3233\/JHD-130077","article-title":"Corpus callosal atrophy in premanifest and early Huntington\u2019s disease","volume":"2","author":"Crawford","year":"2013","journal-title":"J Huntingtons Dis"},{"key":"ref146","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/jnnp.2006.098368","article-title":"Functional connectivity of the prefrontal cortex in Huntington\u2019s disease","volume":"78","author":"Thiruvady","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref147","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1093\/brain\/awac458","article-title":"AAV5-miHTT-mediated huntingtin lowering improves brain health in a Huntington\u2019s disease mouse model","volume":"146","author":"Thomson","year":"2022","journal-title":"Brain"},{"key":"ref148","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1111\/j.1471-4159.2006.04323.x","article-title":"Neurochemical changes in Huntington R6\/2 mouse striatum detected by in vivo 1H NMR spectroscopy","volume":"100","author":"Tkac","year":"2007","journal-title":"J. Neurochem."},{"key":"ref149","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1038\/jcbfm.2012.104","article-title":"Homeostatic adaptations in brain energy metabolism in mouse models of Huntington disease","volume":"32","author":"Tkac","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref150","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1021\/pr050244o","article-title":"Metabolic characterization of the R6\/2 transgenic mouse model of Huntington\u2019s disease by high-resolution MAS 1H NMR spectroscopy","volume":"5","author":"Tsang","year":"2006","journal-title":"J. Proteome Res."},{"key":"ref151","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.neulet.2012.02.095","article-title":"Impaired cortico-striatal functional connectivity in prodromal Huntington\u2019s disease","volume":"514","author":"Unschuld","year":"2012","journal-title":"Neurosci. Lett."},{"key":"ref152","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.tins.2011.06.005","article-title":"Emerging roles for cholesterol in Huntington\u2019s disease","volume":"34","author":"Valenza","year":"2011","journal-title":"Trends Neurosci."},{"key":"ref153","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3174\/ajnr.A3303","article-title":"Magnetization transfer imaging in premanifest and manifest Huntington disease: a 2-year follow-up","volume":"34","author":"van den Bogaard","year":"2013","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"ref154","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3233\/JHD-140117","article-title":"Longitudinal metabolite changes in Huntington\u2019s disease during disease onset","volume":"3","author":"van den Bogaard","year":"2014","journal-title":"J. Huntingtons Dis."},{"key":"ref155","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.2741\/e512","article-title":"MRI biomarkers in Huntington\u2019s disease","volume":"4","author":"van den Bogaard","year":"2012","journal-title":"Front. Biosci."},{"key":"ref156","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.1523\/JNEUROSCI.0590-05.2005","article-title":"Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington\u2019s disease","volume":"25","author":"van Raamsdonk","year":"2005","journal-title":"J. Neurosci."},{"key":"ref157","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/mrm.25174","article-title":"Magnetization transfer from inhomogeneously broadened lines: a potential marker for myelin","volume":"73","author":"Varma","year":"2015","journal-title":"Magn. Reson. Med."},{"key":"ref158","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1002\/jnr.23965","article-title":"Brain diffusivity and structural changes in the R6\/2 mouse model of Huntington disease","volume":"95","author":"Vorisek","year":"2017","journal-title":"J. Neurosci. Res."},{"key":"ref159","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington\u2019s disease","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"key":"ref160","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1021\/acs.jmedchem.0c01133","article-title":"GPR52 antagonist reduces huntingtin levels and ameliorates Huntington\u2019s disease-related phenotypes","volume":"64","author":"Wang","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref161","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fnsys.2010.00016","article-title":"Graph-based network analysis of resting-state functional MRI","volume":"10","author":"Wang","year":"2010","journal-title":"Front. Syst. Neurosci."},{"key":"ref162","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1006\/jmre.1999.1956","article-title":"A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST)","volume":"143","author":"Ward","year":"2000","journal-title":"J. Magn. Reson."},{"key":"ref163","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.expneurol.2008.12.026","article-title":"Longitudinal diffusion tensor imaging in Huntington\u2019s disease","volume":"216","author":"Weaver","year":"2009","journal-title":"Exp. Neurol."},{"key":"ref164","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1002\/hbm.22351","article-title":"Altered resting-state connectivity in Huntington\u2019s disease","volume":"35","author":"Werner","year":"2014","journal-title":"Hum. Brain Mapp."},{"key":"ref165","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/hmg\/11.6.633","article-title":"Early phenotypes that presage late-onset neurodegenerative disease allow testing of modifiers in Hdh CAG knock-in mice","volume":"11","author":"Wheeler","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"ref166","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/hmg\/9.4.503","article-title":"Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice","volume":"9","author":"Wheeler","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"ref167","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1038\/jcbfm.2011.60","article-title":"Magnetic resonance perfusion imaging of resting-state cerebral blood flow in preclinical Huntington\u2019s disease","volume":"31","author":"Wolf","year":"2011","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref168","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1017\/S0033291714000579","article-title":"Abnormal resting-state connectivity of motor and cognitive networks in early manifest Huntington\u2019s disease","volume":"44","author":"Wolf","year":"2014","journal-title":"Psychol. Med."},{"key":"ref169","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.expneurol.2012.06.014","article-title":"Default-mode network changes in preclinical Huntington\u2019s disease","volume":"237","author":"Wolf","year":"2012","journal-title":"Exp. Neurol."},{"key":"ref170","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/mrm.1910100113","article-title":"Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo","volume":"10","author":"Wolff","year":"1989","journal-title":"Magn. Reson. Med."},{"key":"ref171","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.brainresbull.2006.11.004","article-title":"The Hdh(Q150\/Q150) knock-in mouse model of HD and the R6\/2 exon 1 model develop comparable and widespread molecular phenotypes","volume":"72","author":"Woodman","year":"2007","journal-title":"Brain Res. Bull."},{"key":"ref172","doi-asserted-by":"publisher","first-page":"14763","DOI":"10.3390\/ijms232314763","article-title":"A novel Huntington\u2019s disease assessment platform to support future drug discovery and development","volume":"23","author":"Wu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"ref173","doi-asserted-by":"publisher","first-page":"9544","DOI":"10.1523\/JNEUROSCI.1291-11.2011","article-title":"Peroxisome-proliferator-activated receptor gamma coactivator 1 \u03b1 contributes to Dysmyelination in experimental models of Huntington\u2019s disease","volume":"31","author":"Xiang","year":"2011","journal-title":"J. Neurosci."},{"key":"ref174","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","article-title":"Reversal of neuropathology and motor dysfunction in a conditional model of Huntington\u2019s disease","volume":"101","author":"Yamamoto","year":"2000","journal-title":"Cell"},{"key":"ref175","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/mrm.23224","article-title":"Fast macromolecular proton fraction mapping from a single off-resonance magnetization transfer measurement","volume":"68","author":"Yarnykh","year":"2012","journal-title":"Magn. Reson. Med."},{"key":"ref176","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3390\/genes12050712","article-title":"In vivo expression of reprogramming factor OCT4 ameliorates myelination deficits and induces striatal neuroprotection in Huntington\u2019s disease","volume":"12","author":"Yu","year":"2021","journal-title":"Genes (Basel)"},{"key":"ref177","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/jcbfm.2011.157","article-title":"Cortical metabolites as biomarkers in the R6\/2 model of Huntington\u2019s disease","volume":"32","author":"Zacharoff","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref178","doi-asserted-by":"publisher","first-page":"102927","DOI":"10.1016\/j.nicl.2021.102927","article-title":"Timing of selective basal ganglia white matter loss in premanifest Huntington\u2019s disease","volume":"33","author":"Zeun","year":"2022","journal-title":"Neuroimage Clin."},{"key":"ref179","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1016\/j.neuroimage.2009.10.027","article-title":"Longitudinal characterization of brain atrophy of a Huntington\u2019s disease mouse model by automated morphological analyses of magnetic resonance images","volume":"49","author":"Zhang","year":"2010","journal-title":"NeuroImage"},{"key":"ref180","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1093\/hmg\/ddy061","article-title":"Small molecule modulator of protein disulfide isomerase attenuates mutant huntingtin toxicity and inhibits endoplasmic reticulum stress in a mouse model of Huntington\u2019s disease","volume":"27","author":"Zhou","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"ref181","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/nbm.930","article-title":"In vivo 17O NMR approaches for brain study at high field","volume":"18","author":"Zhu","year":"2005","journal-title":"NMR Biomed."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2024.1306312\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T04:22:18Z","timestamp":1707798138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2024.1306312\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,13]]},"references-count":181,"alternative-id":["10.3389\/fnagi.2024.1306312"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2024.1306312","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,13]]},"article-number":"1306312"}}